|
|
2022's Stock Market Performance
|
|
2022's Stock Market Performance
|
2022's Large Cap Stocks Performance
Here are the best and worst performing Large-Cap Stocks of 2022.
The Large-Cap Company is defined with the market capitalization, trading above 5 billion dollars U.S. as of 11/16/26.
2022's Mid Cap Stocks Performance
Here are the best and worst performing companies of 2022 with the market capitalization, trading between 500 million U.S. dollars and 5 billion dollars U.S. respectively, as of 11/16/26.
2022's Small Cap Stocks Performance
The table shows the best and worst performing companies of 2022 with the market capitalization, trading between 50 million U.S. dollars and 500 million dollars U.S. respectively, as of 11/16/26.
2022's Micro Cap Stocks Performance
The list shows the best and worst performing companies of 2022 with the market capitalization, trading under 50 million U.S. dollars, as of 11/16/26.
Who are the 2022's Stock Market Losers?
ATXI
-91.95%
|
|
|
Avenue Therapeutics Inc
Major Pharmaceutical Preparations Industry
ATXI
-91.95%
Avenue Therapeutics Inc is a pharmaceutical company that focuses on the development and commercialization of intravenous (IV) opioids for acute pain management. They aim to address the needs of the hospital-based market by providing innovative and effective IV pain medications. Through research, clinical trials, and partnerships with healthcare providers, Avenue Therapeutics Inc strives to improve healthcare outcomes for patients suffering from acute pain conditions.
|
AIMD
-91.97%
|
|
|
Ainos Inc
Major Pharmaceutical Preparations Industry
AIMD
-91.97%
Ainos Inc is a software development company that generates revenue by providing custom software solutions and consulting services to businesses. They offer tailored software solutions to address specific customer needs and provide consulting expertise to guide companies in optimizing their software development processes.
|
JZXN
-91.99%
|
|
|
Jiuzi Holdings Inc
Automotive Aftermarket Industry
JZXN
-91.99%
Jiuzi Holdings Inc*s business model focuses on a specific area, providing products or services to a targeted market, utilizing unique strategies or technologies, generating revenue through various channels, and potentially expanding to new markets.
|
KOD
-92.00%
|
|
|
Kodiak Sciences Inc
Biotechnology & Pharmaceuticals Industry
KOD
-92.00%
Kodiak Sciences Inc operates as a biopharmaceutical company that focuses on researching, developing, and commercializing innovative therapeutics to treat various retinal diseases. Their business model revolves around the discovery and development of novel drugs, while also conducting clinical trials and pursuing partnerships to bring these therapies to the market.
|
TTCF
-92.05%
|
|
|
Tattooed Chef Inc
Food Processing Industry
TTCF
-92.05%
Tattooed Chef Inc operates as a plant-based food company, offering a range of frozen food products. The company primarily sells its products through various retail channels, including supermarkets, clubs, and online platforms. Tattooed Chef focuses on providing convenient and healthy meal options for consumers looking for plant-based alternatives.
|
ANY
-92.11%
|
|
|
Sphere 3d Corp
Miscellaneous Financial Services Industry
ANY
-92.11%
Sphere 3D Corp is a technology company that focuses on providing virtualization solutions for businesses. They offer products and services that help organizations consolidate their IT infrastructure into virtual environments, resulting in increased efficiency and cost savings.
|
VIVO
-92.14%
|
|
|
Meridian Bioscience Inc
In Vitro & In Vivo Diagnostic Substances Industry
VIVO
-92.14%
Meridian Bioscience Inc operates as a diagnostic test manufacturer and distributor, primarily focused on gastrointestinal diseases and respiratory infections. Their business model involves producing and selling a wide range of diagnostic testing products to healthcare providers, including hospitals, commercial labs, and reference labs, aiming to provide accurate and reliable results for disease detection and monitoring. Through their global sales force, they also offer a comprehensive customer support network and engage in strategic partnerships to expand their market reach and drive growth.
|
ALGS
-92.19%
|
|
|
Aligos Therapeutics Inc
Biotechnology & Pharmaceuticals Industry
ALGS
-92.19%
Aligos Therapeutics Inc*s business model involves developing innovative therapeutics for the treatment of viral diseases.
|
DNTH
-92.35%
|
|
|
Dianthus Therapeutics Inc
Major Pharmaceutical Preparations Industry
DNTH
-92.35%
Dianthus Therapeutics Inc is a biotechnology company that focuses on developing novel genetic medicines for patients suffering from rare genetic diseases. Their business model revolves around leveraging cutting-edge gene therapy technologies to design and deliver innovative treatments. By partnering with academic institutions and utilizing a proprietary gene therapy platform, they aim to address unmet medical needs and provide potential new therapies for patients with genetic disorders.
|
ROOT
-92.42%
|
|
|
Root Inc
Property & Casualty Insurance Industry
ROOT
-92.42%
Root Inc is a consulting firm that specializes in helping companies with strategic alignment and organizational transformation. They partner with businesses to facilitate workshops, design custom solutions, and provide ongoing support and coaching. Root Inc utilizes their expertise in visual thinking and their proprietary methodology to help organizations drive change and achieve their goals.
|
LYLT
-92.47%
|
|
|
Loyalty Ventures Inc
Professional Services Industry
LYLT
-92.47%
Loyalty Ventures Inc is a company that operates on an affiliate marketing business model, focusing on the acquisition and management of online customer loyalty programs. They collaborate with various organizations to create and enhance loyalty programs, driving customer engagement and increasing sales for partner brands. Loyalty Ventures Inc also offers comprehensive analytics and reporting solutions to measure the effectiveness of loyalty programs and provide insights for further growth.
|
NCMI
-92.95%
|
|
|
National Cinemedia Inc
Advertising Industry
NCMI
-92.95%
National CineMedia Inc operates as an advertising and entertainment company in movie theaters across the United States. Their business model involves partnering with movie theaters to sell and display advertisements before movie screenings, providing a platform for brands to reach a captive audience. They also offer other advertising and promotional opportunities to clients, including events, digital displays, and mobile advertising.
|
VTAK
-92.99%
|
|
|
Catheter Precision Inc
Medical Equipment & Supplies Industry
VTAK
-92.99%
Catheter Precision Inc is a medical device manufacturing company that specializes in the production of catheters and related components. The company follows a business-to-business (B2B) model, supplying its products to healthcare institutions, hospitals, and other medical device companies. With its focus on precision and quality, Catheter Precision Inc aims to provide innovative and reliable solutions for various medical procedures involving catheters.
|
REE
-93.03%
|
|
|
Ree Automotive Ltd
EV, Auto & Truck Manufacturers Industry
REE
-93.03%
Ree Automotive Ltd is an automotive technology company that specializes in developing and producing innovative electric vehicle platforms. Their unique business model focuses on designing compact, modular skateboard-like platforms that integrate all vehicle components, offering flexibility to various vehicle manufacturers for customization and rapid production.
|
FAMI
-93.04%
|
|
|
Farmmi Inc
Food Processing Industry
FAMI
-93.04%
Farmmi Inc is a Chinese agricultural products supplier that operates on a business-to-business (B2B) model. They procure, process, and distribute an array of edible fungi products, primarily consisting of mushrooms, to customers including wholesalers, distributors, and retail chains both domestically in China and internationally. By leveraging their supply chain management capabilities and strong industry relationships, Farmmi aims to provide high-quality, traceable agricultural products to meet the demand of their diverse customer base.
|
KPRX
-93.25%
|
|
|
Kiora Pharmaceuticals Inc
Major Pharmaceutical Preparations Industry
KPRX
-93.25%
Kiora Pharmaceuticals Inc operates with a business model focused on the research, development, and commercialization of innovative pharmaceutical products for various medical conditions and diseases. The company aims to create value through the discovery of new drugs, rigorous clinical trials, and strategic partnerships for ultimate patient benefit and sustainable growth.
|
|